Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Insulet to Present at Upcoming Investor Conferences
ACTON, Mass. --(BUSINESS WIRE)--Jul. 26, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that management will present at two upcoming virtual investor conferences: The Canaccord 41 st
View HTML
Toggle Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Action
UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MASSACHUSETTS RAQIM WALKER, derivatively on behalf of INSULET CORPORATION, Plaintiff, v. DUANE DESISTO, PATRICK SULLIVAN, CHARLES LIAMOS, BRIAN ROBERTS, ALLISON DORVAL, JOHN FALLON, SALLY W. CRAWFORD, TIMOTHY J. SCANNELL, STEVEN T.
View HTML
Toggle Summary Insulet to Announce Second Quarter 2021 Financial Results on August 5, 2021
ACTON, Mass. --(BUSINESS WIRE)--Jul. 1, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced plans to release its financial results for the second quarter of 2021 on August 5,
View HTML
Toggle Summary Insulet’s Omnipod® 5 Automated Insulin Delivery System Pivotal Studies Demonstrate Improved Outcomes Across the Lifespan from Ages 2 to 70 years
ACTON, Mass. --(BUSINESS WIRE)--Jun. 26, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced promising results from its latest pivotal trial for the Omnipod 5 Automated
View HTML
Toggle Summary Insulet to Present New Clinical Data for Preschool Children and Adults using the Omnipod® 5 System
ACTON, Mass. --(BUSINESS WIRE)--Jun. 24, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced its schedule of events for the American Diabetes Association (ADA) Virtual 81 st
View HTML
Toggle Summary Insulet Reports First Quarter 2021 Revenue Increase of 27% Year-Over-Year
ACTON, Mass. --(BUSINESS WIRE)--May 6, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced financial results for the three months ended March 31, 2021 .
View HTML
Toggle Summary Insulet to Present at BofA Securities 2021 Virtual Healthcare Conference
ACTON, Mass. --(BUSINESS WIRE)--May 4, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that management will present at the virtual BofA Securities 2021 Health Care Conference on
View HTML
Toggle Summary Insulet 2020 Sustainability Report Conveys Strategy to Deliver Growth with Purpose
ACTON, Mass. --(BUSINESS WIRE)--May 3, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced the publication of its 2020 Sustainability Report.
View HTML
Toggle Summary Insulet Announces Pricing of New Senior Secured Credit Facilities
ACTON, Mass. --(BUSINESS WIRE)--Apr. 29, 2021-- Insulet Corporation (NASDAQ:PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the pricing of a $500 million senior secured term loan B facility (the term
View HTML
Toggle Summary Insulet Announces Launch of Syndication of New Credit Facilities
ACTON, Mass. --(BUSINESS WIRE)--Apr. 19, 2021-- Insulet Corporation (NASDAQ:PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that it has launched the syndication of new senior secured credit facilities,
View HTML
Toggle Summary Insulet to Announce First Quarter 2021 Financial Results on May 6, 2021
ACTON, Mass. --(BUSINESS WIRE)--Apr. 5, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced plans to release its financial results for the first quarter of 2021 on May 6,
View HTML
Toggle Summary Insulet’s Omnipod® 5 Automated Insulin Delivery System Improves Clinical Outcomes in Type 1 Diabetes
ACTON, Mass. --(BUSINESS WIRE)--Mar. 20, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced positive results from the first pivotal trial for the Omnipod ® 5 Automated
View HTML
Toggle Summary Insulet to Host an Investor Webcast to Discuss Omnipod® 5 Pivotal Data
Omnipod 5 is the world’s first tubeless, wearable automated insulin delivery system that continuously adapts insulin delivery based on glucose levels and trends ACTON, Mass. --(BUSINESS WIRE)--Mar. 16, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in
View HTML
Toggle Summary Insulet Reports Full Year 2020 Revenue Increase of 23% and Fourth Quarter 2020 Revenue Increase of 18% Year-Over-Year
Represents 5th Consecutive Year of Over 20% Revenue Growth; Record Quarterly Revenue ACTON, Mass. --(BUSINESS WIRE)--Feb. 23, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System
View HTML
Toggle Summary Insulet to Present at Upcoming Investor Conferences
ACTON, Mass. --(BUSINESS WIRE)--Feb. 8, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at three upcoming virtual investor conferences: The Citi
View HTML